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The present study examined the level of GLUT-4 glucose transporter protein in gastrocnemius muscles of 36 week old genetically obese Zucker 
@ifa) rats and their lean (Fa/-) littermates, and in obese Zucker rats following 18 or 30 weeks of treadmill exercise training. Despite skeletal 
muscle insulin resistance, the level of GLUT-4 glucose transporter protein was similar in lean and obese Zucker rats. In contrast, exercise training 
increased GLUT-4 protein levels by 1.7 and 2.3 fold above sedentary obese rats. These findings suggest endurance training stimulates expression 
of skeletal muscle GLUT-4 protein which may be responsible for the previously observed increase in insulin sensitivity with training. 
Insulin resistance; Skeletal muscle; Obesity; Exercise; Glucose transporter 
1. INTRODUCTION 
The genetically obese (fu/fa) Zucker rat is hyperin- 
sulinemic with impaired glucose tolerance. Previous 
studies have shown the insulin resistance in the obese 
Zucker (fa/fa) rat is due to impaired insulin-stimulated 
glucose uptake by muscle, the primary site of glucose 
disposal [1,2]. Because glucose transport is the rate- 
limiting step in glucose utilization in muscle [3,4] it sug- 
gests the defect in glucose uptake could involve a reduc- 
tion in the abundance of glucose transporter protein. 
Recent studies indicate that skeletal muscle expresses 
a unique tissue-specific glucose transporter protein 
GLUT-4, which is responsible for facilitated glucose 
transport in response to insulin [5-91. The insulin 
resistance of streptozotocin diabetic and fasted rats has 
been shown to correlate closely with decreased GLUT-4 
glucose transporter protein [ 10-131. In the present 
study, we measured skeletal muscle GLUT-4 protein 
levels in genetically obese (fu/fa) Zucker rats and their 
lean littermates (Fa/ - ) in an effort to define the defect 
in glucose utilization at the biochemical evel. 
Endurance exercise training has been demonstrated 
to be an effective means of reducing muscle insulin 
resistance in the obese Zucker rat [ 14,151. However, the 
cellular mechanism(s) underlying the improvement in 
insulin sensitivity with chronic exercise training is not 
known. Glucose transport activity is increased in 
skeletal muscles of trained rats despite little or no 
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alteration in insulin receptor binding [16-191, or 
tyrosine kinase activity [ 17,191 suggesting the 
mechanism of increased glucose transport activity with 
training involves sites distal to the insulin receptor. 
Here we report that chronic endurance training results 
in a significant increase in GLUT-4 glucose transporter 
protein levels in muscle of the obese cfa/fa) Zucker rat. 
2. MATERIALS AND METHODS 
2.1. Reagents 
An affinity purified polyclonal antiserum (ECU4) specific for a 
COOH-terminal synthetic peptide of the GLUT-4 glucose transporter 
161 was raised in rabbits. Reagents for polyacrylamide gel elec- 
trophoresis were obtained from Bio-Rad Laboratories, Richmond, 
CA. ‘2s1-goat anti-rabbit IgG was obtained from ICN 
Radiochemicals (Irvine, CA). Unless otherwise stated, all other 
reagents were obtained from Sigma Chemical Co. (St Louis, MO). 
2.2. Animals, exercise training 
Four week old male lean (Fa/-) and obese (fa/fa) Zucker rats 
were purchased from Charles River Laboratories (Cambridge, MA), 
and provided standard laboratory chow and water ad libitum. Obese 
animals were randomly assigned to an exercise or sedentary group. 
Exercise training began at either a young (6 weeks of age) or later age 
(18 weeks of age) and continued until the rats were 36 weeks of age. 
The exercise protocol consisted of treadmill running at 18 m/min, 
15% grade, 5 days/week for gradually increasing durations during 
the first 2 weeks and thereafter at 20 m/min for 1.5 h/day. This train- 
ing protocol has been demonstrated to increase cytochrome oxidase 
and citrate synthase activity 2 fold in plantaris muscle of obese 
Zucker rats [20,21]. To eliminate any residual effects of the last train- 
ing session, all animals were sacrificed 48 h after the last exercise ses- 
sion after a 10 h fast. The gastrocnemius muscle was excised and 
immediately frozen at - 70°C until preparation. Fasting blood 
samples were obtained at the time of sacrifice. 
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2.3. Glucose and insulin determinations 
Frozen aliquots of serum were thawed and insulin analyzed by dou- 
ble antibody radioimmunoassay with a commercially available kit 
(Immunonuclear) using a rat insulin standard (Eli Lilly & Co.). 
Glucose was measured by the glucose-oxidase method (Boehringer). 
2.4. Western blot analysis 
Muscle (200 mg) was homogenized using a Polytron homogenizer 
in buffer containing 25 mM Hepes, 4 mM EDTA, 25 mM ben- 
zamidine, and 1 pM each of leupeptin, pepstatin and aprotinin. 
Samples were incubated for 1.5 h in 1% Triton X-100 at 4”C, cen- 
trifuged at 2000 rpm, and supernatant removed. Fifty fig of protein 
(BCA procedure, Pierce Chemical Co., Rockford, IL) was subjected 
to SDS-polyacrylamide gel electrophoresis on 8% resolving gel accor- 
ding to Laemmli (221, followed by electrophoretic transfer to an Im- 
mobilon membrane. Membranes were blocked using Carnation 
Low-fat Instant milk, followed by incubation in anti GLUT-4 an- 
tiserum (ECU4, 2 pg protein/ml) and ‘*‘I-anti-rabbit IgG. 
Autoradiographs were quantitated using laser scanning densitometry 
and results expressed relative to an internal standard (30 fig of rat 
heart membrane). For statistical purposes, repeat blots of muscle 
samples from 6-8 separate rats per group were measured by dot blot 
analysis in triplicate. The amount of GLUT-4 protein was scanned 
and compared with dots obtained with the standard. Comparisons 
between lean, obese, and obese-trained were analyzed using one-way 
ANOVA with Neuman-Keuls post-hoc analysis, 
P< 0.05 = significance. 
3. RESULTS 
All observations were made on lean (Fa/ - ) and 
obese uu/fa) Zucker rats sacrificed at 36 weeks of age. 
At this age, the&$ rat is obese (body mass 160 f 4%, 
mean f SE, P<O.Ol), hyperinsulinemic (528 + 80070, 
P<O.Ol), and normoglycemic (105 f 8%, NS) com- 
pared with lean (Fa/-) littermates (Table I). Obese 
rats were exercise trained for either 18 or 30 weeks. 
Trained rats had significantly (P<O.O5) lower body 
mass than sedentary obese rats. Fasting insulin levels 
were lower but not significantly less in both exercise 
groups compared to obese controls. However, fasting 
glucose was significantly less (P<O.O5) in the 30 week 
trained obese rats compared to obese controls. 
The effect of obesity and exercise training on levels 
of GLUT-4 glucose transporter protein was measured 
by Western blot analysis using polyclonal antiserum 
ECU4 (Fig. 1). Quantitation by laser densitometry 
Table I 
Body weight, fasting plasma glucose and insulin concentrations in 36 
week old lean (Fa/-), obese cfa/fa), and obese-trained Zucker rats 
Group Body mass Plasma insulin Plasma glucose 
(g) &U/ml) (mm) 
Lean (Fa/-) 398 * 4** 92+ 13** 8.6 x 0.4 
Obese (fa/fa) 637 f 17 486 * 74 9.0 i 0.7 
Obese-trained 542 k 26* 372 * 58 8.5 + 0.7 
18 week 
Obese-trained 570 r 1-Y 432 + 49 7.4 f 0.3* 
30 week 
Mean + SE, n = 4-7 animals/group. *Significantly less than obese 
nontrained (fa/fa) group, P<O.O5 **Significantly less than all obese 
groups, PcO.01 
14 
Fig. 1. Muscle glucose transporter GLUT-4 protein in skeletal muscle 
of lean Fa/ - (LN), obesefa/fa (ON), obese exercise trained 30 week 
(OT30wk), and obese exercise trained 18 week (OTlbwk) Zucker rats. 
Protein (50 pg) from mixed gastrocnemius muscle was extracted, sub- 
jected to SDS-PAGE, transferred to immobilion membrane, and im- 
munoblotted with polyclonal antibody (ECU4) to GLUT-4 protein as 
described in section 2. 
0 LEAN CONTROL 
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Fig. 2. GLUT-4 protein in gastrocnemius muscle from lean (Fa/ - ), 
obese (fa/fa), obese exercise trained (18 week), and obese exercise 
trained (30 week) Zucker rats. GLUT-4 protein was measured by 
quantitative immunoblotting as described in section 2. Results are 
based on scanning densitometry obtained from Western blot analysis 
shown in Fig. 1, mean + SE, n = 3. Similar results were obtained us- 
ing dot blot analysis: ‘J/o of standard = lean 34.6 + 1.5 1 (n = 6); obese 
32.5 + 1.27 (n = 6); obese trained 30 week 45.4 + 4.9 (n = 7), P<O.O5 
vs sedentary obese rats. 
showed similar levels of GLUT-4 for lean and seden- 
tary obese rats (Fig. 2). However, exercise training of 
obese rats for 18 or 30 weeks increased GLUT-4 levels 
by 1.7 and 2.3 fold, respectively, relative to sedentary 
obese rats. To confirm these finndings, muscles 
(6-8/group) from lean, obese, and obese 30 week train- 
ed rats were analyzed by dot blot, and revealed a 
significant increase in GLUT-4 protein (P< 0.05) in the 
30 week trained group, and no differences between lean 
and obese sedentary rats. 
4. DISCUSSION 
One of the primary biochemical adaptations to en- 
durance exercise training is an increase in mitochon- 
drial protein and oxidative capacity of the muscle [23]. 
Our results now show that adaptation to chronic en- 
durance training also results in the synthesis of a 
specific protein which facilitates glucose transport into 
the muscle cell. As yet, very little is known about the 
mechanism(s) (neural, humoral, biochemical) responsi- 
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ble for the increase in GLUT-4 protein with training. 
However, we recently observed that in addition to in- 
creased glucose transport and insulin sensitivity, red 
slow twitch skeletal muscle has up to 5 times more 
GLUT-4 protein than white muscle [24]. This observa- 
tion suggests that increased GLUT-4 protein with exer- 
cise training could be mediated by contractile activity 
per se, since a number of investigators have shown that 
muscles chronically stimulated to contract take on the 
biochemical characteristics of slow twitch muscle 
[25,26]. 
Several studies have found that the mechanism of in- 
creased glucose uptake by skeletal muscle following 
acute endurance exercise is through translocation of 
pre-existing glucose transporters to the cell surface 
[27-291. The present results demonstrate that exercise 
training results in the synthesis of new glucose 
transporters, specifically the GLUT-4 transporter 
isoform. Increased number of glucose transporters as 
estimated by D-glucose inhibitable cytochalasin-B bin- 
ding have been demonstrated previously in adipocytes 
of endurance trained rats along with increased glucose 
transport [30,31]. Presumably, these changes are the 
result of transcriptional regulation of glucose 
transporter mRNA. 
Previous studies have shown that skeletal muscle is 
the primary tissue responsible for whole body insulin 
resistance in human obesity [32]. The genetically obese 
Zucker (fa/fa) rat has proven to be a useful model for 
the study of mechanisms of insulin resistance because 
of the well characterized defect in insulin-stimulated 
glucose uptake by skeletal muscle [1,2,15]. Although 
insulin receptor binding is decreased in soleus muscle 
from obese Zucker rats compared with lean rats [ 1,331, 
the major mechanism underlying the insulin resistance 
in obese Zucker rats resides in the glucose transport 
system [2,34]. In the current study we found that the 
previously observed defect in glucose transport is not 
accompanied by a depletion of the GLUT-4 glucose 
transporter protein. These data are similar to a recent 
report examining GLUT-4 protein in muscles from the 
young ob/ob mouse, another model of obesity and in- 
sulin resistance [35]. Thus, the insulin resistance in 
these genetic forms of obesity is not due to depletion of 
GLUT-4 glucose transporter protein in skeletal muscle. 
While very little is known about the signal transduction 
pathway involved, a major mechanism by which insulin 
increases glucose uptake is through translocation of 
glucose transporters from an intracellular compartment 
to the cell surface 1361. The present results suggest hat 
the defect in glucose transport in obese Zucker rats may 
be related to changes in signal transduction, transloca- 
tion, or functional activity of the glucose transporter. 
Both insulin and glucose have been suggested as im- 
portant factors regulating expression of glucose 
transporters. In insulin deficient states such as diabetes 
and fasting, there is a 50-60% decrease in GLUT-4 
mRNA along with a 5087% decrease in GLUT-4 pro- 
tein in adipose cells [lo-121 and skeletal muscle [ 131. 
However, when glucose is increased independantly of 
insulin, glucose transporter protein gene expression and 
protein are reduced in skeletal muscle [37-381. Our fin- 
ding that GLUT-4 protein levels are unchanged in 
obese Zucker rats, despite severe hyperinsulinemia nd 
normal blood glucose suggests, at least in this model, 
that GLUT-4 protein levels are not altered by hyperin- 
sulinemia. On the other hand, exercise training which 
decreased fasting glucose without significantly altering 
insulin levels, induced a significant increase in GLUT-4 
protein. This finding supports, albeit indirectly, the 
role of glucose in the regulation of GLUT-4 protein 
levels. 
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